Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook by...
David A. Ricks
We're buying the post-earnings slump in a stock alongside Tim Cook. It's not Apple
We're buying 200 shares of Nike at roughly $59. Following Wednesday's trade, Jim Cramer's Charitable Trust will own 1,600 shares...
Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025....
